Cargando…

Long-Term Cholecalciferol Administration in Hemodialysis Patients: A Single-Center Randomized Pilot Study

BACKGROUND: Data on the potent pleiotropic extraskeletal effects of vitamin D have renewed interest in its use in selected populations, including patients with chronic kidney disease, but the available data are still insufficient to make recommendations. This study assessed the long-term effect of s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mieczkowski, Mariusz, Żebrowski, Paweł, Wojtaszek, Ewa, Stompór, Tomasz, Przedlacki, Jerzy, Bartoszewicz, Zbigniew, Sierdziński, Janusz, Wańkowicz, Zofia, Niemczyk, Stanisław, Matuszkiewicz-Rowińska, Joanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2014
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238795/ https://www.ncbi.nlm.nih.gov/pubmed/25382402 http://dx.doi.org/10.12659/MSM.892315

Ejemplares similares

Cholecalciferol vs. Small Doses of Alfacalcidol vs. Placebo in Chronic Kidney Disease Patients on Hemodialysis: A Randomized Parallel Group Study
por: Matuszkiewicz-Rowińska, Joanna, et al.
Publicado: (2022)

Homeostatic model assessment indices in evaluation of insulin resistance and secretion in hemodialysis patients
por: Niemczyk, Stanisław, et al.
Publicado: (2013)

Patients’ and healthcare personnel expectations for SARS-CoV-2 screening in dialysis unit during the Covid-19 pandemic
por: Przedlacki, Jerzy, et al.
Publicado: (2020)

Peritoneal Ultrafiltration in the Long-Term Treatment of Chronic Heart Failure Refractory to Pharmacological Therapy
por: Wojtaszek, Ewa, et al.
Publicado: (2019)

Visceral Adipose Tissue is Associated with Insulin Resistance in Hemodialyzed Patients
por: Giers, Kinga, et al.
Publicado: (2015)

Is Free Testosterone Concentration a Prognostic Factor of Survival in Chronic Renal Failure (CRF)?
por: Niemczyk, Stanisław, et al.
Publicado: (2015)

Urgent-Start Peritoneal Dialysis as a Bridge to Definitive Chronic Renal Replacement Therapy: Short- and Long-Term Outcomes
por: Wojtaszek, Ewa, et al.
Publicado: (2019)

Renal amyloidosis in Whipple disease: a case report
por: Niemczyk, Stanislaw, et al.
Publicado: (2009)

Comparison of Second- and Third-Generation Parathyroid Hormone Test Results in Patients with Chronic Kidney Disease
por: Wójtowicz, Magdalena, et al.
Publicado: (2020)

Limitations of the of the oscillometric method for blood pressure measurements in dialyzed patients
por: Czarkowski, Marek, et al.
Publicado: (2011)

Left Ventricular Diastolic Dysfunction in Chronic Kidney Disease Patients Not Treated with Dialysis
por: Romejko, Katarzyna, et al.
Publicado: (2022)

Resistin Contribution to Cardiovascular Risk in Chronic Kidney Disease Male Patients
por: Romejko, Katarzyna, et al.
Publicado: (2023)

The prevalence of hepatitis C and B among patients on hemodialysis and on renal transplantation waiting list in Poland has significantly decreased during the last 10 years
por: Malyszko, Jolanta, et al.
Publicado: (2018)

Serum Osteoprotegerin Is an Independent Marker of Metabolic Complications in Non-DialysisDependent Chronic Kidney Disease Patients
por: Rymarz, Aleksandra, et al.
Publicado: (2021)

Serum Osteoprotegerin Is an Independent Marker of Left Ventricular Hypertrophy, Systolic and Diastolic Dysfunction of the Left Ventricle and the Presence of Pericardial Fluid in Chronic Kidney Disease Patients
por: Romejko, Katarzyna, et al.
Publicado: (2022)

Relationships between Sclerostin, Leptin and Metabolic Parameters in Non-Dialysis Chronic Kidney Disease Males
por: Romejko, Katarzyna, et al.
Publicado: (2022)

A randomized controlled trial of cholecalciferol supplementation in patients on maintenance hemodialysis
por: Bansal, Beena, et al.
Publicado: (2014)

Age-related differences in the quality of life in end-stage renal disease in patients enrolled in hemodialysis or continuous peritoneal dialysis
por: Laudański, Krzysztof, et al.
Publicado: (2013)

Contribution of volume overload to the arterial stiffness of hemodialysis patients
por: Czyżewski, Łukasz, et al.
Publicado: (2017)

Oral Postdialysis Cholecalciferol Supplementation in Patients on Maintenance Hemodialysis: A Dose-Response Approach
por: Descombes, Eric, et al.
Publicado: (2014)

Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems
por: Matuszkiewicz-Rowińska, Joanna, et al.
Publicado: (2015)

Urinary and Serum Biomarkers for Prediction of Acute Kidney Injury in Patients Undergoing Liver Transplantation
por: Lewandowska, Lidia, et al.
Publicado: (2019)

Selected Legal Aspects of Donation After Circulatory Death in Poland
por: Guzik-Makaruk, Ewa M., et al.
Publicado: (2019)

Vaccination and COVID-19 in Polish Dialysis Patients: Results from the European Clinical Dialysis Database
por: Marcinkowski, Wojciech, et al.
Publicado: (2022)

Effect of Nitric Oxide Pathway Regulation on Water/Sodium Balance and Renal Function in a Rodent Model of Acute Liver and Renal Failure
por: Saracyn, Marek, et al.
Publicado: (2014)

D-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure?
por: Saracyn, Marek, et al.
Publicado: (2015)

Denial Defense Mechanism in Dialyzed Patients
por: Nowak, Zbigniew, et al.
Publicado: (2015)

Comparable Hemodilution with Hypertonic Glucose in Patients with and without Type-2 Diabetes Mellitus during Hemodialysis
por: Schneditz, Daniel, et al.
Publicado: (2023)

Multi-Method Complex Approach for Hydration Assessment Does Not Detect a Hydration Difference in Hemodialysis versus Peritoneal Dialysis Patient
por: Adamska-Wełnicka, Anna, et al.
Publicado: (2020)

Cardiovascular Response to Intravenous Glucose Injection during Hemodialysis with Assessment of Entropy Alterations
por: Niemczyk, Longin, et al.
Publicado: (2022)

The Influence of Different Cholecalciferol Supplementation Regimes on 25(OH) Cholecalciferol, Calcium and Parathyroid Hormone after Bariatric Surgery
por: Smelt, Hendrika J.M., et al.
Publicado: (2019)

Albuminuria and hyperhomocysteinemia as cardiovascular risk factors in potentially healthy soldiers: A long-term observation
por: Kade, Grzegorz, et al.
Publicado: (2012)

Effect of Cholecalciferol Supplementation on Inflammation and Cellular Alloimmunity in Hemodialysis Patients: Data from a Randomized Controlled Pilot Trial
por: Li, Lily, et al.
Publicado: (2014)

Iron metabolism in hemodialyzed patients – a story half told?
por: Malyszko, Jolanta, et al.
Publicado: (2014)

Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency
por: Sosa Henríquez, Manuel, et al.
Publicado: (2020)

Vancomycin dosing in patients undergoing maintenance hemodialysis
por: Rymarz, Aleksandra, et al.
Publicado: (2014)

Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients
por: Zheng, Cai-Mei, et al.
Publicado: (2018)

Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
por: Rymuza, Joanna, et al.
Publicado: (2018)

The role of technological progress vs. accidental discoveries and clinical experience in the evolution of dialysis
por: Wańkowicz, Zofia
Publicado: (2013)

Evaluation of one-alpha-hydroxy-cholecalciferol alone or in combination with cholecalciferol in Ca—P deficiency diets on development of tibial dyschondroplasia in broiler chickens
por: Landy, Nasir, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vqjsfetl5u7sgjo44ron4996n9